2019 Fiscal Year Final Research Report
The relationship between cancer-associted fibroblast and mast cell on the osteolysis of cancer induced bone disease
Project/Area Number |
17H04405
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Surgical dentistry
|
Research Institution | Okayama University |
Principal Investigator |
Sasaki Akira 岡山大学, 医歯薬学総合研究科, 教授 (00170663)
|
Co-Investigator(Kenkyū-buntansha) |
岸本 晃治 岡山大学, 医歯薬学総合研究科, 助教 (40243480)
志茂 剛 北海道医療大学, 歯学部, 教授 (40362991)
奥井 達雄 岡山大学, 大学病院, 助教 (40610928)
吉岡 徳枝 岡山大学, 医歯薬学総合研究科, 助教 (50362984)
伊原木 聰一郎 岡山大学, 医歯薬学総合研究科, 准教授 (80549866)
|
Project Period (FY) |
2017-04-01 – 2020-03-31
|
Keywords | マスト細胞 / 癌骨破壊病変 / 癌関連線維芽細胞 / 血管新生 / 口腔扁平上皮癌 / 破骨細胞 / 骨浸潤 / ケミカルメディエーター |
Outline of Final Research Achievements |
Osteoclastic bone resorption plays an important role in bone invasion of cancer and bone destruction of bone metastases. Cancer-associated fibroblasts (B-CAF) present in the bone microenvironment of cancer bone-destructive lesion play an important role in the mechanism. On the other hand, mast cells, which are immune cells, are known to perform various functions such as angiogenesis of cancer, matrix degradation, and production of inflammatory substances related to pain. In this study, we investigated the mechanism of bone destruction by the interaction between B-CAF and mast cells. As a result, mast cells are induced in the cancer bone microenvironment, and their production factors not only directly promote osteoclastogenic bone resorption, but also induce bone resorption, matrix degradation, angiogenesis, etc. for B-CAF. It was suggested to be involved in bone destruction through facilitation and interaction.
|
Free Research Field |
外科系歯学
|
Academic Significance and Societal Importance of the Research Achievements |
現有の骨破壊病変に対する骨吸収阻害薬は顎骨壊死を誘発する問題があり,新たな戦略が必要である。マスト細胞が癌の進展や血管新生に関わることは知られているが,癌の骨破壊における癌関連線維芽細胞(B-CAF)とマスト細胞の相互機構に注目した報告は殆どない。研究成果は,B-CAFを標的とした新規治療の開発であり,骨微小環境でのマスト細胞の役割や局所環境でのB-CAFの応答遺伝子の探索は創薬研究の基盤となる。
|